Graduate Programme OHNU Seminar – April 29, 2025 !

French version


The Graduate Programme OHNU – Oncology, Hematology, and Nuclear Medicine – is organizing a seminar on Tuesday, April 29, 2025.

PROGRAMME 

WELCOME

4:00 PM - 4:15 PM - IRS-UN - Amphitheater Denis ESCANDE

Introduction
Prof. Cyrille Touzeau, Clinical Hematology Department, Nantes University Hospital

[Conferences]

4:15 PM - 4:45 PM
Prof. Léo RASCHE, University Hospital, Würzburg, Germany – Physician in Medicine at Würzburg University Hospital

  • Présentation of Prof. Dr. med. Léo Rasche
  • Conference and discussion: : « patial-temporal evolution of multiple myeloma »

4:45 PM - 5:15 PM

Prof. Hector Peinado, Head of the Microenvironment and Metastasis Group, Spanish National Cancer Research Centre (CNIO)

5:15 PM - 5:45 PM
Dr. Gatien Moriceau, Associate (Adjunct) Professor at UCLA, Los Angeles, California, USA – UCLA Jonsson Comprehensive Cancer Center Researcher

  • Presentation of Dr. Gatien Moriceau: Dr. Moriceau is an Associate Professor of Medicine at the University of California, Los Angeles (UCLA). He earned his PhD in Cancer Biology from the University of Nantes, specializing in osteosarcoma. His current research focuses on developing next-generation therapies to overcome advanced metastatic melanoma. His laboratory combines preclinical testing of innovative therapies with temporal and spatial multi-omic profiling to understand therapeutic resistance and exploit cancer vulnerabilities.
  • Conference and discussion : "Next-Generation Therapeutics to Defeat Melanoma"

5:45 PM - 6:15 PM

Dr. Ludivine Morvan, PhD, Senior Research Scientist at AlgoDx, FINGERS Brain Health Institute (Solna, Sweden)

  • Présentation of Dr Morvan
  • Conference and discussion " Leveraging Machine Learning for progression prediction: Application to Multiple Myeloma and PET images"

6:15 PM - 6:25 PM
Closing Remarks

6:25 PM - 7:30 PM - Hall 4, IRS-UN
Networking & Informal Discussions

Contact : Sandrine PERNOT <Sandrine.Pernot@univ-nantes.fr>
Mis à jour le 17 février 2025.